Sort
51,593 grants matching “hepatitis”
Multi-center, randomized, controlled trial of the feasibility and safety of inhaled hydrogen gas during ECPR
$768,213John Nagi Kheir · Boston Children'S Hospital · R33 · FY2024 · HL
Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention
$767,863Lynn Elizabeth Fiellin · Yale University · R01 · FY2009 · AA
Revolutionary Eilat-based Chikungunya Vaccine Vector
$767,732Tian Wang · University Of Texas Med Br Galveston · R01 · FY2020 · AI
Comprehensive Interrogation of Toxicity Profiles Associated with Novel CAR T-cell Constructs
$767,708Nirali Shah · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Human Cytomegalovirus Entry into Cells Mediated by Pentamer and Trimer Complexes
$767,673David C. Johnson · Oregon Health & Science University · R01 · FY2020 · AI
Early Life Exposure to Endocrine Disrupting Chemicals: Epigenomic and Transcriptomic Networks and RAGE in Liver Disease
$767,662Lindsey Starr Trevino · Beckman Research Institute/City Of Hope · R01 · FY2024 · ES
Early Life Exposure to Endocrine Disrupting Chemicals: Epigenomic and Transcriptomic Networks and RAGE in Liver Disease
$767,661Lindsey Starr Trevino · Beckman Research Institute/City Of Hope · R01 · FY2025 · ES
Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism
$767,571Byoung-Joon Song · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2010 · AA
The Impact of Mitochondrial Repression and Lipid Accumulation by HIF on Tumor Growth
$767,523Amato J. Giaccia · Stanford University · R35 · FY2017 · CA
The Impact of Mitochondrial Repression and Lipid Accumulation by HIF on Tumor Growth
$767,523Amato J. Giaccia · Stanford University · R35 · FY2016 · CA
The Impact of Mitochondrial Repression and Lipid Accumulation by HIF on Tumor Growth
$767,523Amato J. Giaccia · Stanford University · R35 · FY2018 · CA
Vascular Targeting of Nanocarriers for RNA
$767,434Vladimir R Muzykantov · University Of Pennsylvania · R01 · FY2024 · HL
Physiological and therapeutic effects of ANGPTL3 variants in mice and humans
$767,297Marina Cuchel · University Of Pennsylvania · R01 · FY2020 · HL
A vascularized patient-derived iPSC liver acinus microphysiology system as an innovative precision medicine platform for optimizing clinical trial design for nonalcoholic fatty liver disease
$767,285D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · UH3 · FY2022 · TR
Impairment of anti-Plasmodium T cell memory by type I Interferon Signaling
$767,280Nana Kwaku Minkah · Seattle Children'S Hospital · R01 · FY2025 · AI
Modeling HIV/AIDS Associated Neurological Disorders with Human Pluripotent Cells
$767,250Tariq M Rana · University Of California, San Diego · DP1 · FY2016 · DA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$767,212James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Alimentary Tract Lipids in Health and Disease
$767,165Martin Conrad Carey · Brigham And Women'S Hospital · R37 · FY2008 · DK
Cardiovascular risk from comprehensive evaluation of the CT calcium score exam
$767,135David L Wilson · Case Western Reserve University · R01 · FY2025 · HL
Discovery of Antivirals Targeting Mpox Virus
$767,057Stefan G Sarafianos · Emory University · R01 · FY2025 · AI
Risk Factors for AIDS among Persons Who Inject Drugs: HIV and COVID-19
$767,023Don C Des Jarlais · New York University · R01 · FY2023 · DA
Biobehavioral Studies of Obesity, Weight loss and Recidivism
$767,008Ranganath Muniyappa · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Glycoprotein Remodeling in the Vasculopathy and Coagulopathy of Sepsis
$766,997Jamey Marth · University Of California Santa Barbara · R01 · FY2014 · HL
AIDS Clinical Trial Group Laboratory Center
$766,819Grace M. Aldrovandi · University Of California Los Angeles · UM1 · FY2025 · AI
Neutralizing antibody responses during natural control of acute hepatitis B with and without HIV-1 coinfection
$766,615Justin Richard Bailey · Johns Hopkins University · R01 · FY2022 · AI